Prevención y Tratamiento de la Enfermedad Injerto Contra Huésped (EICH)
Prevention and Treatment of Graft-versus-Host Disease (GVHD) - Video in Spanish
Webinar
You are here
CAR T-cells in Non-Hodgkin Lymphoma, A Hopeful Option
CAR T-cell therapy is a promising treatment for patients who have relapsed (the disease came back after treatment) or refractory (the disease did not respond to intial thereapy) non-Hodgkin lymphoma.
COVID-19: Precautions, Vaccines and Treatments for Transplant Recipients
Learn how stem cell transplant recipients can best protect themselves against COVID-19, and newest treatment options available if you do get COVID-19.
Transplantation for Myelodysplastic Syndromes (MDS): Who, When and How
More than 60,000 people have myelodysplastic syndrome (MDS) in the U.S. Learn about the best treatment options.
Acute Myeloid Leukemia: Increasing Complexity and Increasing Treatment Opportunities
Learn about the different types of acute myeloid leukemia (AML), how it is treated, and when transplant is the best option.
CAR T-cell Therapy for Patients with Multiple Myeloma
CAR T-cell and other new drugs are expanding treatment options for patients with myeloma.
The Scars You Can’t See Are the Hardest to Heal: Coping with the Impact of Graft versus Host Disease
Learn how Acceptance and Commitment Therapy can improve mental well-being.
Treatment Options for Sickle Cell Disease
Bone marrow transplants and gene therapy for sickle cell disease: treatment options to consider.
Live Your Best Life: How to Manage Fatigue and Adapt Routines to Maximize Quality of Life with GVHD
Learn how occupational therapists can help you improve your quality of life.
COVID 19 Winter Update: What Transplant Recipients Need to Know
With cases of COVID-19 on the rise this winter, it's important to have the latest facts about your risk for getting a severe case of COVID-19.
